Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vincent

Showing results (741-750 of 785) with videos related to

Pageof 79
Sort By:
Pharmacy (Basel, Switzerland)|August 27, 2021
Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in PsychopharmacologyHervé Javelot, Clara Gitahy Falcao Faria, Frederik Vandenberghe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2014
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancerF Rothé, J-F Laes, D Lambrechts, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 19, 2017
Associations of Undiagnosed Obstructive Sleep Apnea and Excessive Daytime Sleepiness With Depression: An Australian Population StudyCarol J Lang, Sarah L Appleton, Andrew Vakulin, et al.
Breast Cancer Research and Treatment|December 4, 2012
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancerJorma J de Ronde, Esther H Lips, Lennart Mulder, et al.
Breast Cancer Research : BCR|January 29, 2014
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patientsKarin Beelen, Mark Opdam, Tesa M Severson, et al.
Breast Cancer Research : BCR|January 23, 2014
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatmentKarin Beelen, Mark Opdam, Tesa M Severson, et al.
Journal of Occupational and Environmental Medicine|February 10, 2026
Assessing the Carcinogenic Potential of Jet Fuels: A Fit-for-Purpose Systematic Literature ReviewElizabeth R Heitz, Barrett D Allen, Samantha J Goodman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2013
Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapyBas B Koolen, Kenneth E Pengel, Jelle Wesseling, et al.
Breast (Edinburgh, Scotland)|February 19, 2013
FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancerBas B Koolen, Kenneth E Pengel, Jelle Wesseling, et al.
Frontiers in Neuroinformatics|August 12, 2021
A Simulation Toolkit for Testing the Sensitivity and Accuracy of Corticometry PipelinesMona OmidYeganeh, Najmeh Khalili-Mahani, Patrick Bermudez, et al.
Pageof 79

Showing results (741-750 of 785) with videos related to

Sort By:
Pageof 79
Pharmacy (Basel, Switzerland)|August 27, 2021
Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in PsychopharmacologyHervé Javelot, Clara Gitahy Falcao Faria, Frederik Vandenberghe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2014
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancerF Rothé, J-F Laes, D Lambrechts, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 19, 2017
Associations of Undiagnosed Obstructive Sleep Apnea and Excessive Daytime Sleepiness With Depression: An Australian Population StudyCarol J Lang, Sarah L Appleton, Andrew Vakulin, et al.
Breast Cancer Research and Treatment|December 4, 2012
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancerJorma J de Ronde, Esther H Lips, Lennart Mulder, et al.
Breast Cancer Research : BCR|January 29, 2014
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patientsKarin Beelen, Mark Opdam, Tesa M Severson, et al.
Breast Cancer Research : BCR|January 23, 2014
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatmentKarin Beelen, Mark Opdam, Tesa M Severson, et al.
Journal of Occupational and Environmental Medicine|February 10, 2026
Assessing the Carcinogenic Potential of Jet Fuels: A Fit-for-Purpose Systematic Literature ReviewElizabeth R Heitz, Barrett D Allen, Samantha J Goodman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2013
Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapyBas B Koolen, Kenneth E Pengel, Jelle Wesseling, et al.
Breast (Edinburgh, Scotland)|February 19, 2013
FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancerBas B Koolen, Kenneth E Pengel, Jelle Wesseling, et al.
Frontiers in Neuroinformatics|August 12, 2021
A Simulation Toolkit for Testing the Sensitivity and Accuracy of Corticometry PipelinesMona OmidYeganeh, Najmeh Khalili-Mahani, Patrick Bermudez, et al.
Pageof 79